fingolimod hydrochloride has been researched along with Atherogenesis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, H; Ishida, T; Ishima, Y; Kusumoto, K; Ogawa, M; Okuhira, K; Shimizu, T; Tachibana, K | 1 |
| Fan, Y; Gong, TT; Lei, L; Liang, X; Liu, H; Shan, ZY; Sun, RZ; Wang, Q | 1 |
| Bäck, N; Bittman, R; Blom, T; de Lera, A; Diczfalusy, U; Ikonen, E; Kovanen, PT; Li, Z; Mutka, AL | 1 |
| Bode, C; Gräler, M; Heusch, G; Keul, P; Levkau, B; Lucke, S; von Wnuck Lipinski, K | 1 |
| Hla, T; Obinata, H | 1 |
| Bergonzini, V; Costa, S; Galletti, M; Nofer, JR; Pignatti, E; Poti, F; Simoni, M; Weber, C | 1 |
| Heusch, G; Keul, P; Levkau, B; Lucke, S; Schuchardt, M; Tölle, M; van der Giet, M; von Wnuck Lipinski, K | 1 |
| Assmann, G; Biessen, EA; Bot, M; Brinkmann, V; Brodde, M; Nofer, JR; Salm, P; Taylor, PJ; van Berkel, T | 1 |
| Kleuser, B; Levkau, B; Tölle, M; van der Giet, M | 1 |
| Bea, F; Blessing, E; Dengler, TJ; Grone, HJ; Hansson, GK; Katus, HA; Klingenberg, R; Nofer, JR; Preusch, M; Rudling, M | 1 |
2 review(s) available for fingolimod hydrochloride and Atherogenesis
| Article | Year |
|---|---|
Sphingosine 1-phosphate in coagulation and inflammation.
Topics: Animals; Atherosclerosis; Blood Coagulation; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Inflammation; Lymph Nodes; Lymphocytes; Lysophospholipids; Multiple Sclerosis; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Propylene Glycols; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Tumor Necrosis Factor-alpha | 2012 |
Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds.
Topics: Anti-Inflammatory Agents; Apoptosis; Atherosclerosis; Endothelial Cells; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lysophospholipids; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine | 2007 |
8 other study(ies) available for fingolimod hydrochloride and Atherogenesis
| Article | Year |
|---|---|
FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages.
Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; Cholesterol; Fingolimod Hydrochloride; Foam Cells; Liver X Receptors; Mice; Phosphotransferases (Alcohol Group Acceptor) | 2022 |
Rapamycin and FTY720 Alleviate Atherosclerosis by Cross Talk of Macrophage Polarization and Autophagy.
Topics: Animals; Arginase; Atherosclerosis; Autophagy; Biomarkers; Cyclooxygenase 2; Fingolimod Hydrochloride; Foam Cells; Interleukin-6; Lipoproteins, LDL; Macrophages, Peritoneal; Membrane Glycoproteins; Mice; Microtubule-Associated Proteins; Nitric Oxide Synthase Type II; Receptors, Lysosphingolipid; Sirolimus; Transforming Growth Factor alpha | 2018 |
FTY720 stimulates 27-hydroxycholesterol production and confers atheroprotective effects in human primary macrophages.
Topics: Apolipoprotein A-I; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Biological Transport; Carrier Proteins; Cell Culture Techniques; Cell Death; Cell Survival; Cells, Cultured; Cholesterol; Cholesterol Esters; Endoplasmic Reticulum; Endosomes; Fingolimod Hydrochloride; Humans; Hydroxycholesterols; Intracellular Signaling Peptides and Proteins; Lipoproteins, LDL; Liver X Receptors; Macrophages; Membrane Glycoproteins; Niemann-Pick C1 Protein; Orphan Nuclear Receptors; Propylene Glycols; Receptors, Scavenger; Signal Transduction; Sphingosine; Time Factors | 2010 |
Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Movement; Cell Proliferation; Disease Models, Animal; Fingolimod Hydrochloride; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Peritonitis; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Sphingosine-1-Phosphate Receptors; Thioglycolates | 2011 |
Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Atherosclerosis; Body Weight; CD11b Antigen; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Fingolimod Hydrochloride; Genes, MHC Class II; Indans; Interleukin-2; Interleukin-6; Lymph Nodes; Lymphocyte Activation; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Oxadiazoles; Proprotein Convertases; Propylene Glycols; Receptors, LDL; Receptors, Lysosphingolipid; Serine Endopeptidases; Sphingosine; Spleen | 2012 |
The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Movement; Cells, Cultured; Cholesterol, Dietary; Cytokines; Disease Models, Animal; Fingolimod Hydrochloride; Gene Expression Regulation; Immunohistochemistry; Lysophospholipids; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Probability; Propylene Glycols; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sphingosine; Statistics, Nonparametric | 2007 |
FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Topics: Animals; Atherosclerosis; Cell Division; Cholesterol, HDL; Cytokines; Disease Models, Animal; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Lymphocyte Count; Lymphocytes; Lysophospholipids; Macrophages; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Propylene Glycols; Receptors, LDL; Signal Transduction; Sphingosine; Triglycerides | 2007 |
Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Fingolimod Hydrochloride; Hypercholesterolemia; Immunosuppressive Agents; Lipid Metabolism; Lymphocyte Subsets; Lymphocytes; Lymphopenia; Lysophospholipids; Male; Mice; Mice, Knockout; Propylene Glycols; Sphingosine; Spleen | 2007 |